Shares
Starting May 3, Beyond Meat will roll out the newest version of its vegan Beyond Burger at retailers nationwide. The new iteration of the plant-based burger aims to better compete with animal-derived beef in a number of ways. The new Beyond Burger has 35 percent less saturated fat (and 35 percent less overall fat) than an 80/20 beef patty. The new patty is fortified with B vitamins and minerals comparable to the nutritional profile of beef. Whereas the brand’s original Beyond Burger was sold in two-patty packs, the new iteration will be available in both two-patty packs and bulk four-patty packs ($9.99) to better compete with the price of beef. The new vegan meat will also be offered as a one-pound Beyond Beef pack later this summer.
email article
The investigational hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor vadadustat was noninferior to the erythropoiesis-stimulating agent darbepoetin alfa for treating anemia in chronic kidney disease (CKD) patients, a pair of phase III trials found.
2TECT Study of non-dialysis-dependent CKD treatment with vadadustat met the pre-specified noninferiority endpoint for hematologic efficacy compared with darbepoetin alfa, reported Glenn Chertow, MD, MPH, of Stanford University School of Medicine in California, and colleagues.
Looking only at ESA-untreated patients, there was an average between-group hemoglobin concentration difference of 0.05 g/dL (95% CI -0.04 to 0.15) maintained from weeks 24 to 36 with vadadustat or darbepoetin alfa treatment.
DermTech to Collaborate on Longitudinal Study on Hidradenitis Suppurativa (HS) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
E-Mail
Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations. This case study was conducted by investigators at Children s Hospital Los Angeles and is published in the journal
Most people are infectious for about 10 days after first showing COVID-19 symptoms. In this study, researchers describe two children and a young adult with acute lymphoblastic leukemia who tested positive for SARS-CoV-2 for months. This is the first report of prolonged infection in a pediatric or young adult population.